Over the past century, advances in biotechnology, biochemistry, and pharmacognosy have spotlighted flavonoids, polyphenolic secondary metabolites that have the ability to modulate many pathways involved in various biological mechanisms, including those involved in neuronal plasticity, learning, and memory. Moreover, flavonoids are known to impact the biological processes involved in developing neurodegenerative diseases, namely oxidative stress, neuroinflammation, and mitochondrial dysfunction. Thus, several flavonoids could be used as adjuvants to prevent and counteract neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Zebrafish is an interesting model organism that can offer new opportunities to study the beneficial effects of flavonoids on neurodegenerative diseases. Indeed, the high genome homology of 70% to humans, the brain organization largely similar to the human brain as well as the similar neuroanatomical and neurochemical processes, and the high neurogenic activity maintained in the adult brain makes zebrafish a valuable model for the study of human neurodegenerative diseases and deciphering the impact of flavonoids on those disorders.
This study provided new data and knowledge on the potential use of Hermetia illucens meal (HIM) as a new sustainable ingredient for Sparus aurata diet. The effect of HIM dietary inclusion on fish growth performance, stress indicators and gut histology was studied. For 131 days, 312 fish were fed a basal diet containing fishmeal as animal protein source, and three diets containing 25%, 35% and 50% HIM as a partial replacement for fishmeal. The main findings indicated that fishmeal can be replaced by HIM up to 110 g/kg of substitution (35% of inclusion in diet) without negative effects on growth performance, stress parameters or histological traits of the posterior gut tract, and with positive effects (p < 0.05) on the histological and morphometric characteristics of the anterior gut tract. At the same time, the results showed that the effect of Hermetia illucens meal at 50% inclusion level caused morphometric and histopathological alterations in the anterior gut tract of seabream. In conclusion, this preliminary study suggested that the dietary inclusion level of HIM35 was the most tolerated by fish showing the best gut morphometric parameters and histological conditions, with fewer signs of inflammation, as well as good nutritional and health status.
The effect of defatted Hermetia illucens meal (HIM) dietary inclusion on growth performance, stress indicators and gut histological traits of Sparus aurata was studied. For 131 days, 312 fish were fed with one basal diet, containing fish meal as animal protein source, and three diets containing 25%, 35% and 50% HIM as a partial replacement for fishmeal. On all fish (26 fish per tank, 3 replicate tanks per diet, 78 fish per diet) the growth performance were calculated. At the end of the trial, on a subsample of 72 specimens (6 fish per tank, 3 replicate tanks per diet, 18 fish per diet), stress parameters were determined on blood samples and gut histological tract investigated. Insect meal inclusion did not affect (p > 0.05) growth performance, blood parameters, length and width of villi and goblet cell count of the posterior gut tract while, those of the anterior gut tract while increased (p < 0.05). The histological examination of the intestinal sections showed in fish fed the HIM25 and HIM50 diets, more frequent and evident morphological changes; instead, there were no substantial differences between HIM0 and HIM35 groups. In conclusion, the HIM35 was the most tolerated formulation by fish.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.